MWM
DCPH icon

Mascoma Wealth Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Mascoma Wealth Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40
Closed -$2K – 416
2018
Q2 		$2K Buy
+40
New +$1.18K ﹤0.01% 372

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Polar Capital
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mascoma Wealth Management's DCPH Position: Q3 2018 in Review

Mascoma Wealth Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2018, closing a stake of 40 shares — an estimated $2K sold.

Mascoma Wealth Management first reported a position in DCPH in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 88 funds tracked by Wall St. Rank hold DCPH as of Q3 2018.

  • Mascoma Wealth Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Mascoma Wealth Management sold 40 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $2K.
  • Mascoma Wealth Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Mascoma Wealth Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Mascoma Wealth Management's 13F filing for Q3 2018, filed 8 Nov 2018.